本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Neurosense Therapeutics Ltd

0.5108
+0.109227.19%
盤後0.4825-0.0283-5.54%19:58 EDT
成交量:422.41萬
成交額:193.42萬
市值:1,929.09萬
市盈率:-1.17
高:0.5257
開:0.4000
低:0.3600
收:0.4016
52周最高:1.98
52周最低:0.2500
股本:3,776.61萬
流通股本:2,584.64萬
量比:32.93
換手率:16.34%
股息:- -
股息率:- -
每股收益(TTM):-0.4366
每股收益(LYR):-0.4366
淨資產收益率:-2174.98%
總資產收益率:-247.30%
市淨率:-12.37
市盈率(LYR):-1.17

資料載入中...

2026/03/31

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/11/25

SEC問詢函

Form CORRESP - Correspondence
2025/08/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/04/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/16

SEC問詢函

Form CORRESP - Correspondence
2025/01/06

SEC問詢函

Form CORRESP - Correspondence
2024/12/13

SEC問詢函

Form CORRESP - Correspondence
2024/12/09

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/22

SEC問詢函

Form CORRESP - Correspondence
2024/11/19

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/05/21

SEC問詢函

Form CORRESP - Correspondence
2024/05/20

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/10

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/04/04

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/04

SEC問詢函

Form CORRESP - Correspondence
2023/09/01

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/08/31

SEC問詢函

Form CORRESP - Correspondence
2023/08/15

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]